The company reports encouraging results of its GERD treatment in Indian trials.
Medigus Ltd. (TASE:MDGS) plans to apply to the US Food and Drug Administration (FDA) to conduct human clinical trials of its SRS System endoscope treatment device for Gastroesophageal Reflux Disease (GERD) following encouraging results of a trial in India. The company plans to carry out the US trials at several medical centers.
Dr. Amol Bapaye carried out the trials on four patients at the Deenanath Mangeshkar Hospital and Research Center in Puna on August 11-12. He said the preliminary results were very encouraging, and that the anatomical results of the procedure were the same as the results of surgical procedures. He said that a routine examination could not distinguish the results of the SRS procedure from the current surgical procedure.
On the basis of accumulated clinical trial results at the hospital, Dr. Bapaye reported that the SRS System was a breakthrough in the treatment of GERD.
Published by Globes [online], Israel business news - www.globes.co.il - on August 22, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007